ARVINAS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
ARVINAS, INC. (ARVN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 49.81 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-03.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-11-03
- ARVINAS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 49.81M shares, a 27.52% increase year-over-year.
- ARVINAS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 48.86M shares, a 26.13% increase year-over-year.
- ARVINAS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 48.62M shares, a 26.13% increase year-over-year.
- ARVINAS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 41.78M shares, a 11.91% increase year-over-year.
- ARVINAS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 39.53M shares, a 20.06% increase from fiscal 2019.
- ARVINAS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 32.93M shares, a 249.45% increase from fiscal 2018.
- ARVINAS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 9.42M shares, a 396.58% increase from fiscal 2017.
- ARVINAS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 1.90M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-09-30 | 49.81M shares 10-Q · filed 2021-11-03 | 49.33M shares derived: average of 2 quarters · filed 2021-11-03 | 49.10M shares 10-Q · filed 2021-11-03 | 47.27M shares derived: average of 4 quarters · filed 2021-11-03 |
| 2021-06-30 | 48.86M shares 10-Q · filed 2021-08-05 | 48.74M shares 10-Q · filed 2021-08-05 | 46.42M shares derived: average of 3 quarters · filed 2021-08-05 | 44.58M shares derived: average of 4 quarters · filed 2021-11-03 |
| 2021-03-31 | 48.62M shares 10-Q · filed 2021-05-04 | 45.20M shares derived: average of 2 quarters · filed 2021-05-04 | 43.15M shares derived: average of 3 quarters · filed 2021-11-03 | 42.05M shares derived: average of 4 quarters · filed 2021-11-03 |
| 2020-12-31 | 41.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 40.42M shares derived: average of 2 quarters · filed 2021-11-03 | 39.86M shares derived: average of 3 quarters · filed 2021-11-03 | 39.53M shares 10-K · filed 2021-03-01 |
| 2020-09-30 | 39.06M shares 10-Q · filed 2021-11-03 | 38.90M shares derived: average of 2 quarters · filed 2021-11-03 | 38.78M shares 10-Q · filed 2021-11-03 | 38.42M shares derived: average of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | 38.74M shares 10-Q · filed 2021-08-05 | 38.64M shares 10-Q · filed 2021-08-05 | 38.21M shares derived: average of 3 quarters · filed 2021-08-05 | 36.84M shares derived: average of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | 38.55M shares 10-Q · filed 2021-05-04 | 37.94M shares derived: average of 2 quarters · filed 2021-05-04 | 36.21M shares derived: average of 3 quarters · filed 2021-05-04 | 35.02M shares derived: average of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | 37.34M shares 10-K · filed 2020-03-16 | 35.04M shares derived: average of 2 quarters · filed 2020-11-05 | 33.84M shares derived: average of 3 quarters · filed 2020-11-05 | 32.93M shares 10-K · filed 2021-03-01 |
| 2019-09-30 | 32.74M shares 10-Q · filed 2020-11-05 | 32.09M shares derived: average of 2 quarters · filed 2020-11-05 | 31.88M shares 10-Q · filed 2020-11-05 | 31.65M shares derived: average of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | 31.44M shares 10-Q · filed 2020-08-04 | 31.41M shares 10-Q · filed 2020-08-04 | 31.29M shares derived: average of 3 quarters · filed 2020-08-04 | 23.97M shares derived: average of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | 31.33M shares 10-Q · filed 2020-04-28 | 31.21M shares derived: average of 2 quarters · filed 2020-04-28 | 21.48M shares derived: average of 3 quarters · filed 2020-04-28 | 16.58M shares derived: average of 4 quarters · filed 2020-04-28 |
| 2018-12-31 | 31.10M shares 10-K · filed 2020-03-16 | 16.55M shares derived: average of 2 quarters · filed 2020-03-16 | 11.67M shares derived: average of 3 quarters · filed 2020-03-16 | 9.42M shares 10-K · filed 2021-03-01 |
| 2018-09-30 | 2.01M shares 10-K · filed 2020-03-16 | 1.95M shares derived: average of 2 quarters · filed 2020-03-16 | 1.94M shares 10-Q · filed 2019-11-04 | 1.93M shares derived: average of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | 1.90M shares 10-K · filed 2020-03-16 | 1.90M shares 10-Q · filed 2019-08-05 | 1.90M shares derived: average of 3 quarters · filed 2020-03-16 | 1.90M shares derived: average of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | 1.90M shares 10-K · filed 2020-03-16 | 1.90M shares derived: average of 2 quarters · filed 2020-03-16 | 1.90M shares derived: average of 3 quarters · filed 2020-03-16 | 1.90M shares derived: average of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | 1.90M shares 10-K · filed 2019-03-26 | 1.90M shares derived: average of 2 quarters · filed 2019-03-26 | 1.90M shares derived: average of 3 quarters · filed 2019-03-26 | 1.90M shares 10-K · filed 2019-03-26 |
| 2017-09-30 | 1.90M shares 10-K · filed 2019-03-26 | 1.90M shares derived: average of 2 quarters · filed 2019-03-26 | 1.90M shares 10-Q · filed 2018-11-14 | |
| 2017-06-30 | 1.90M shares 10-K · filed 2019-03-26 | 1.90M shares derived: average of 2 quarters · filed 2019-03-26 | ||
| 2017-03-31 | 1.90M shares 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |